Intestifix

5 trials 5 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

5 Recruiting

0 Completed trials

4 Sponsors

1 Countries

Phase II

Phase I/II

Phase II: 4 Phase I/II: 1

Indications tested

Crohn's disease 1 Hepatic cirrhosis 1

Sponsors using this IMP

Goethe University Frankfurt 2 Klinikum der Universitaet Muenchen AöR 1 Universitaetsklinikum Aachen AöR 1 Universitaetsklinikum Heidelberg AöR 1

All trials

5 total

Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMIT… Recruiting

2025-520452-28-00 Phase II 1 country Goethe University Frankfurt
A Randomized controlled open-label phase II trial assessing the efficacy and safety of two-dosing regimens of frozen encapsulated fecal micr… Recruiting

2024-519748-34-00 Phase II 1 country Goethe University Frankfurt
Encapsulated Fecal Microbiota Transfer to Treat Immune Activation in Patients with Cirrhosis and Ascites (TransImmune) – A randomized, doubl… Recruiting

2023-507790-18-00 Phase II 1 country Universitaetsklinikum Aachen AöR
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab – A randomized, placebo-controlled, double-blin… Recruiting

2023-506887-15-00 Phase II 1 country Universitaetsklinikum Heidelberg AöR
EEN-RICH study Recruiting

2022-503027-10-00 Phase I/II 1 country Klinikum Der Universitat Munchen AöR

Showing 1–5 of 5 trials

← All drugs A–Z